Who we are

ARUK Network 2016

Our network is a collaboration between various departments at Oxford University, Oxford Brookes University and Reading University.

To find out more about being part of the Network Centre, contact us at aruk.administrator@dpag.ox.ac.uk / tel: 01865 282358.

Many of our members are also part of the OxDARE research network whose directory can be searched here.

Oxford ARUK Organising Committee

Name:	Institution:
Richard Wade-Martins	Department of Physiology, Anatomy and Genetics, University of Oxford @WadeMartinsLab Works on understanding molecular mechanisms of age-related neurodegenerative diseases to generate novel molecular therapies
Angela Bithell	Department of Pharmacy, University of Reading Interested in the molecular and cellular mechanisms that underlie normal developmental of the central nervous system (CNS) and CNS-related disorders.
Christopher Butle r	Nuffield Department of Clinical Neurosciences, University of Oxford Research focusses on understanding the memory deficits experienced by patients with damage to the medial temporal lobes of the brain.
Steven Chance	Nuffield Department of Clinical Neurosciences, University of Oxford Interested in the relationship between brain structure and function - particularly language and social cognition
Mark Dallas	Department of Pharmacy, University of Reading @drmarkdallas Working to unravel new therapeutic targets for a host of neurodegenerative diseases
Helen Dawes	Faculty of Health and Life Sciences at Oxford Brookes University @helendawes2 Research spans from exploring underlying mechanisms affecting performance through to service delivery of subsequently developed interventions and tools. Research has three themes: movement, rehabilitation and exercise.
Patrick Esser	Movement Science Group, Oxford Brookes University. Research interests lie within the broad field of biomechanics with a particular interest in movement analysis in (non-) neurological conditions.
Simon Lovestone	Department of Psychiatry, University of Oxford @Simon_Lovestone Research on the molecular pathogenesis of and biomarkers for Alzheimer's disease.
Clare Mackay	Department of Psychiatry, University of Oxford @ClareEMacKay @OxDARE Research focuses on using neuroimaging to understand risk for psychiatric and neurodegenerative disease.
Rupert McShane	DeNDRoN / Oxford University Hospitals NHS Trust Interested in dementia and in treatment resistant depression. Leads the Thames Valley DeNDRoN local research network, which supports a wide variety of studies in dementia and neurological disease

Current members of the Oxford Network Centre

Neuroscience, Molecular Biology, primary cell culture

Clinical neurology, neuroimaging, cognition

Name	Affiliation
Members A-C
Bryan Adriaanse	Nuffield Department of Clinical Neurosciences, University of Oxford	Cellular and molecular biology
Samrah Ahmed	Nuffield Department of Clinical Neurosciences, University of Oxford	Cognitive tests, neuropsychology
Colin Akerman	Department of Pharmacology, University of Oxford	Cellular and molecular biology
Zoi Alexopoulou	Nuffield Department of Clinical Neurosciences, University of Oxford	Fly genetics, cell-based assays, genomics and neuropathology
Sneha Anand	Department of Psychiatry. University of Oxford	Blood & CSF analysis, cellular and molecular biology
Olaf Ansorge	Nuffield Department of Clinical Neurosciences, University of Oxford	Molecular neuropathology
Alison Baird	Department of Psychiatry. University of Oxford	Blood & CSF analysis, cellular and molecular biology, cohorts, imaging
Imelda Barber	Department of Psychiatry. University of Oxford	Molecular Biology, Biostatistics, Bioinformatics
Jill Betts	Department of Psychiatry and FMRIB Centre at the University of Oxford	Fitness training with MRI scanning and cognitive assessment
Angela Bithell	Department of Pharmacy, University of Reading	Cellular and molecular biology
Paul Brennan	Structural Genomics Consortium, University of Oxford	Epigenetics, target discovery, parallel organic synthesis
Christopher Butler	Nuffield Department of Clinical Neurosciences, University of Oxford	Experimental psychology & cognitive neuroscience, electrophysiology (EEG), imaging
Tara Caffrey	Department of Physiology, Anatomy and Genetics, University of Oxford	Cellular and molecular biology, genetics & genomics
Phillippa Carling	Department of Physiology, Anatomy and Genetics, University of Oxford	Cell Biology, Molecular Biology, Neuroscience, target discovery, iPSc
Steven Chance	Nuffield Department of Clinical Neurosciences, University of Oxford	Imaging, neuropathology
Sharon Christie	Nuffield Department of Clinical Neurosciences, University of Oxford	Clinical research nurse
Helen Collins	DeNDRoN / Oxford University Hospitals NHS Trust	Research delivery manager
Sally Cowley	James Martin Stem Cell Facility, William Dunn School of Pathology	Cellular and molecular biology, genetics & genomics
Members D-I
Mark Dallas	Department of Pharmacy, University of Reading	Cellular and molecular biology, electrophysiology (EEG), imaging, pharmacology
Ruxandra Mutihac Dafinca	Nuffield Department of Clinical Neurosciences, University of Oxford	iPSc, ALS, FTD, phenotypes, drug discovery
Adria Dangla Valls	Department of Psychiatry. University of Oxford	iPSc, clusterin, henotypic readout, rodent models
John Davis	Alzheimer's Research UK Oxford Drug Discovery Institute	CSO of ARUK Oxford Drug Discovery Institute
Helen Dawes	Faculty of Health and Life Sciences at Oxford Brookes University	Movement, rehabilitation and exercise
Stephane De Cesco	Target Discovery Institute, Oxford	Computational chemistry, target discovery
Gabriele De Luca	Nuffield Department of Clinical Neurosciences, University of Oxford	Cellular and molecular biology, genetics & genomics, neuropathology
Naiara Demnitz	Department of Psychiatry, University of Oxford	MRI, cognitive psychology, exercise, brain structure and function
Elena Di Daniel	Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford	Target validation, drug discovery, iPSc
Sarah Dixon-Clarke	Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford	Structural Biology, X-ray crystallography
Matthias Ehebauer	Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford	Biotechnology, molecular biology, structural biology
Katherine England	Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford	Discovery of chemical probes
Margaret Esiri	Nuffield Department of Clinical Neurosciences, University of Oxford	Genetics & genomics, neuropathology
Patrick Esser	Movement Science Group, Oxford Brookes University	Biomechanics, movement analysis
Oleg Fedorov	Structural Genomics Consortium, University of Oxford	Chemical probe discovery, Epigenetics
Nicola Filippini	Department of Psychiatry, University of Oxford	Epidemiology/ cohort studies, fMRI, MRI
Evangeline Foster	Department of Psychiatry, University of Oxford	Clusterin protein, CRISPR/CAS-9, iPSc
Menuka Pallebage Gamarallage	Nuffield Department of Clinical Neurosciences, University of Oxford	In vivo physiology, behaviour, histology
Mariacarmela Giurrandino	Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford	Drug discovery
Ludovica Griffanti	Nuffield Department of Clinical Neurosciences, University of Oxford	MRI, multi-modal imaging, biomarkers
Walther Haenseler	James Martin Stem Cell Facility, Sir William Dunn School of Pathology	Cellular and molecular biology
Anne-Marie Haigh	Nuffield Department of Clinical Neurosciences, University of Oxford	Cognitive tests, fMRI, genetics, histopathology, neuropsychology
Cheryl Hawkes	Department of Life, Health & Chemical Sciences, Open University	Transgenic models, cellular and molecular biology, neuropathology
Anja Hayen	School of Psychology & Clinical Language Sciences, University of Reading	Nutrition, cognition and healthy ageing
Members J-M
Catherine Joachim	Nuffield Department of Clinical Neurosciences, University of Oxford
Timothy Johanssen	ARUK Oxford Drug Discovery Institute, University of Oxford	Protein aggregation, molecular neurobiology, cell culture, prion protein, rna technology
Carole Johnston	Department of Pharmacology, University of Oxford	Lab manager
Keely Jones	ARUK Oxford Drug Discovery Institute, University of Oxford	Oxford Drug Discovery Institute Administrator
Eleni Kaisis	Reading School of Pharmacy	Cell biology, molecular biology, neuroscience
Loukia Katsouri	ARUK Oxford Drug Discovery Institute, University of Oxford	Histology, neuroscience, physiology
Chi-Hun Kim	Department of Psychiatry, University of Oxford	Clinical bioinformatics
Ivan Koychev	Department of Psychiatry, University of Oxford	Biomarkers, psychiatry
Charmaine Lang	Department of Physiology, Anatomy and Genetics, University of Oxford	Cellular and molecular biology, genetics & genomics
Jennifer Lawson	Department of Psychiatry, University of Oxford	Phenotyping, biomarkers
Cecilia (Heyne) Lee	James Martin Stem Cell Facility, Sir William Dunn School of Pathology	Cellular and molecular biology
Donald Lehmann	Department of Pharmacology, University of Oxford	Genetic epidemiology
Simon Lovestone	Department of Psychiatry, University of Oxford	Clinical trials, cohorts
Clare Mackay	Department of Psychiatry, University of Oxford	Experimental psychology and cognitive neuroscience, genetics & genomics, imaging
Sebastian Mathea	ARUK Oxford Drug Discovery Institute, University of Oxford	Drug discovery
Jenny McCleery	DeNDRoN / Oxford University Hospitals NHS Trust	Clinical trials
Ellen McCulloch	Nuffield Department of Medicine, University of Oxford	Clinical research nurse
Rupert McShane	DeNDRoN / Oxford University Hospitals NHS Trust	Clinical trials, pharmacology, service evaluation
Claire Merritt	DeNDRoN / Oxford University Hospitals NHS Trust	Lead research nurse manager
Emma Murphy	ARUK Oxford Drug Discovery Institute
Susannah Murphy	Oxford Centre for Human Brain Activity, University of Oxford	Experimental psychology & cognitive neuroscience, imaging, genetics & genomics
Members N-R
Alejo Nevado-Holgado	Department of Psychiatry, University of Oxford	Cellular and molecular biology, clinical trials, cohorts, epidemiology /cohort studies, genetics & genomics, neuropathology, pharmacology
Danielle Newby	Department of Psychiatry, University of Oxford	Computational methods, healthy ageing
Francesca Nicholls	Department of Psychiatry, University of Oxford	ARUK Early Careers Representative Cellular biology, high-throughput screening
Sohaib Nizami	Nuffield Department of Medicine, University of Oxford	Neuroscience, Molecular Biology, primary cell culture
Shereen Nizari	Department of Life, Health & Chemical Sciences, Open University	Neuroscience, histology, cell biology
Kia Nobre	Department of Experimental Psychology, University of Oxford	Experimental psychology & cognitive neuroscience, imaging
Laura Parkkinen	Nuffield Department of Clinical Neurosciences, University of Oxford	Transgenic models, blood & CSF analysis, cognitive tests, genetics, histopathology, immunohistochemistry molecular biology
Sarah Pendlebury	Nuffield Department of Clinical Neurosciences, University of Oxford	Cohorts, experimental psychology & cognitive neuroscience, service evaluation
Richard Priestley	Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford	Target validation and assay development
Cynthia Prendergast	Department of Pharmacology, University of Oxford	Pharmacology
Ilaria Poggiolini	Nuffield Department of Clinical Neurosciences, University of Oxford	Biomarkers, neuropathology
Clare Rathbone	Department of Psychology, Oxford Brookes University	Cognitive psychology
Elena Ribe	Department of Psychiatry, University of Oxford	Translational Neuroscience, animal models
Helga Refsum	Department of Pharmacology, University of Oxford	Blood & CSF analysis, clinical trials, epidemiology/cohort studies, genetics & genomics
Jacqueline Robbins	Target Discovery Institute, University of Oxford	Translational Neuroscience, cellular & molecular biology
Hazel Roberts	ARUK Oxford Drug Discovery Institute, and the James Martin Stem Cell Facility, University of Oxford.	Microglia, iPSc, cellular & molecular biology
David Ruvolo	Department of Psychiatry, University of Oxford	Project coordinator for the European Prevention of Alzheimer's Disease (EPAD) project
Brent Ryan	Department of Physiology, Anatomy and Genetics, University of Oxford	Phenotypes, high-throughput screens, iPSc, mass spectrometry
Members S-Z
Irene Sechi	Target Discovery Institute, University of Oxford	Target discovery
Claire Sexton	Department of Psychiatry, University of Oxford	Cohorts, imaging
Carolyn Sloan	Nuffield Department of Clinical Neurosciences, University of Oxford	Laboratory manager, Neuropathology department
David Smith	Department of Pharmacology, University of Oxford	Pharmacology, imaging
Sana Suri	Department of Psychiatry, University of Oxford	Genetics, MRI, neuroimaging
Aleksandra Szykowska	Structural Genomics Consortium, Oxford University	Crystallography, protein purification
Kevin Talbot	Nuffield Department of Clinical Neurosciences, University of Oxford	Transgenic models, cellular & molecular biology, clinical trials
Laura Thei	Department of Psychiatry, University of Oxford	Transgenic models, cellular and molecular biology, imaging, neuropathology
George Tofaris	Nuffield Department of Clinical Neurosciences, University of Oxford	Cellular and molecular biology
Mario Torso	Nuffield Department of Clinical Neurosciences, University of Oxford	Experimental psychology & cognitive neuroscience
Anya Topiwala	Department of Psychiatry, University of Oxford	Neuroimaging, longitudinal epidemiological studies, cognition
Martin Turner	Nuffield Department of Clinical Neurosciences, University of Oxford	Blood & CSF analysis, experimental psychology & cognitive neuroscience, imaging, genetics & genomics
Carien van Reekum	School of Psychology and Clinical Language Sciences, University of Reading	Cognitive neuroscience, psychopathology
Michele Veldsman	Nuffield Department of Clinical Neurosciences, University of Oxford	FTD, genetics, stroke
Siv Vingill	Department of Physiology, Anatomy and Genetics, University of Oxford	Transgenic models, cellular and molecular biology, genetics & genomics
Katharina Wagner	Department of Physiology, Anatomy and Genetics, University of Oxford	Transgenic models, translated mRNAs
Richard Wade-Martins	Department of Physiology, Anatomy and Genetics, University of Oxford. Oxford Parkinson's Disease Centre.	Transgenic models, cellular and molecular biology, genetics & genomics
Donald Warden	Department of Pharmacology, University of Oxford	Molecular biology
Sarah Westwood	Department of Psychiatry, University of Oxford	Blood & CSF analysis
Emma Whiteley	Department of Physiology, Anatomy and Genetics and Department of Pharmacology, University of Oxford	Cellular and molecular biology, electrophysiology (EEG), neuropathology, pharmacology
Gordon Wilcock	Nuffield Department of Clinical Neurosciences, University of Oxford	Clinical trials, experimental psychology & cognitive neuroscience
Claire Williams	School of Psychology & Clinical Language Sciences at the University of Reading	Behaviour; nutrition & cognition
Sarsha Wilson	Oxford Health NHS Foundation Trust	Clinical care, neurodegeneration
Melanie Witt	Department of Physiology, Anatomy and Genetics, University of Oxford	ARUK Oxford network administrator
Stephen Wren	Target Discovery Institute, University of Oxford	Alzheimer’s drug discovery.
Caroline Woffindale	Translational Neuroscience and Dementia Research Group, University of Oxford	Translational Neuroscience, bioinformatics
Giovanna Zamboni	Nuffield Department of Clinical Neurosciences, University of Oxford	Clinical neurology, neuroimaging, cognition

Who we are

Oxford ARUK Organising Committee

Current members of the Oxford Network Centre

Members A-C

Members D-I

Members J-M

Members N-R

Members S-Z

On this page